BIOT
Protein Indication Switching: Challenges Costs and Solutions!
⚠️ Switching indications for established protein molecules can present challenges in manufacturing and patent protection. 🏭💊📜💡
UK Biotech Company Receives Grant to Revolutionize Cell and Gene Therapy
📢 Exciting News! MicrofluidX receives UK grant to enhance its cell and gene therapy platform for improved scalability, cost-effectiveness, and efficiency. 💉🧬🚀
Cutting-Edge Bioanalytics Revolutionize AAV Research and Manufacturing
📅 Dec 12, 2023: Explore the crucial innovations in bioanalytics for AAVs, from R&D to manufacturing. 💡🧪🌐
Revolutionary Method Boosts AAV Capsid Purification!
📅 Dec 12, 2023: Study reveals high-resolution chromatography method to boost AAV capsid purification. 💉🧬 Improved gene therapy potential!
Slash Healthcare Costs with Game-Changing Biosimilars
🔍 Discover how biosimilars can reduce healthcare costs by delivering the same efficacy at a lower price. 💊💰🏥🧬🔬
Cytomos Revolutionizes Advanced Therapy Manufacturing with Cell Characterization Tech
📢 Cytomos is revolutionizing advanced therapy manufacturing with their unique technology to monitor and detect potential batch failures. 💡
Major Milestone: Charles River & Vertex Revolutionize Cell Therapy Manufacturing
📅 Dec 18, 2023: Charles River Laboratories achieves milestone in manufacturing CASGEVY, first FDA-approved CRISPR therapy for sickle cell disease. 🙌🔬
Unlocking Protein Product Opportunities: Overcoming Challenges with QTL Technology
📢 Recombinant proteins have the potential to transform industries, but technical challenges hinder their commercial scaling. 👉 Inaccurate risk assessments prevent the exploration of protein product possibilities. 🚀 Scaling protein manufacture requires substantial investment and addressing technical complexity. 💡 Quantitative Trait Loci (QTL) technology enables tailored manufacturing solutions for individual products. ✅ QTL technology can overcome technical challenges and unlock commercial opportunities for protein products.
Revolutionary Scandinavian Bioinks for Regenerative Medicine
🧪 Scandinavian scientists have developed bioinks for regenerative medicine that combine dynamic and nondynamic linkages. 🧫 These bioinks can be used for cellular interactions in 3D and in vivo implantation. 🩹 Three hydrogels were developed, with the DT-gel being the most promising for cartilage regeneration. 💡 The D-gel has potential for wound healing and cancer cell metastasis research. 🔬 The T-gel supports cell proliferation and stability. 🔎 The hydrogels showed stability in a buffer environment and increased expressions of stemness markers. 🌱 Future research aims to explore the chondrogenic properties of the hydrogels for cartilage regeneration and tissue model construction.
Uncovering the Tender Trap: How Biosimilar Policymaking Impacts Access to Affordable Medicines
🏭 Manufacturing innovations may reshape biosimilar policymaking, leading to lower prices and increased accessibility. 💉🌍
